The genes involved include those related to the hypothalamus-pituitary-adrenal axis and to the serotonin transporter, COMT that degrades dopamine and noradrenaline, as well as NPY and BDNF. It would be of interest to see if similar genetic polymorphisms are more frequent in people with ALS. This evidence concerns the gene NPY and amyotrophic lateral sclerosis.